Janssen's Zytiga fails to impress NICE
02 February 2012
Francesca Bruce
Please Login to read the full article.
02 February 2012
Francesca Bruce
Please Login to read the full article.
RELATED CONTENT
NEWS
- NICE U-turn puts Janssen's Zytiga ahead of Sanofi's Jevtana in prostate cancer
- Scots choose chewy Lipitor but refuse Zytiga, Sycrest and Gilenya
- Sanofi turns to G-BA for Jevtana benefits decision after vague IQWiG's assessment
- Added benefit for Janssen's Zytiga for some patients, says German HTA body
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
